Annual ROE
-20.39%
+45.67%+69.13%
31 December 2023
Summary:
Y-mAbs Therapeutics annual return on equity is currently -20.39%, with the most recent change of +45.67% (+69.13%) on 31 December 2023. During the last 3 years, it has risen by +57.93% (+73.97%). YMAB annual ROE is now at all-time high.YMAB ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-24.45%
+0.15%+0.61%
30 September 2024
Summary:
Y-mAbs Therapeutics quarterly return on equity is currently -24.45%, with the most recent change of +0.15% (+0.61%) on 30 September 2024. Over the past year, it has dropped by -6.25% (-34.34%). YMAB quarterly ROE is now -53.58% below its all-time high of -15.92%, reached on 31 December 2017.YMAB Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YMAB ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +69.1% | -34.3% |
| 3 y3 years | +74.0% | -17.4% |
| 5 y5 years | +33.8% | +60.9% |
YMAB ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +74.0% | -34.3% | +71.2% |
| 5 y | 5 years | at high | +74.0% | -34.3% | +72.2% |
| alltime | all time | at high | +85.6% | -53.6% | +72.2% |
Y-mAbs Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -24.45%(-0.6%) |
| June 2024 | - | -24.60%(+16.5%) |
| Mar 2024 | - | -21.12%(+3.1%) |
| Dec 2023 | -20.39%(-69.1%) | -20.49%(+12.6%) |
| Sept 2023 | - | -18.20%(-47.7%) |
| June 2023 | - | -34.81%(-42.2%) |
| Mar 2023 | - | -60.19%(-13.6%) |
| Dec 2022 | -66.06%(+70.9%) | -69.65%(-17.9%) |
| Sept 2022 | - | -84.81%(+14.9%) |
| June 2022 | - | -73.81%(+30.8%) |
| Mar 2022 | - | -56.41%(+100.7%) |
| Dec 2021 | -38.66% | -28.11%(+34.9%) |
| Sept 2021 | - | -20.83%(-12.7%) |
| June 2021 | - | -23.86%(-38.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | -38.51%(-56.1%) |
| Dec 2020 | -78.32%(+92.2%) | -87.80%(+14.1%) |
| Sept 2020 | - | -76.98%(+2.7%) |
| June 2020 | - | -74.98%(+16.8%) |
| Mar 2020 | - | -64.21%(+2.8%) |
| Dec 2019 | -40.74%(+32.3%) | -62.48%(-0.1%) |
| Sept 2019 | - | -62.52%(+39.2%) |
| June 2019 | - | -44.92%(+5.6%) |
| Mar 2019 | - | -42.52%(+18.3%) |
| Dec 2018 | -30.79%(+32.0%) | -35.95%(-5.7%) |
| Sept 2018 | - | -38.12%(-8.8%) |
| June 2018 | - | -41.81%(+67.0%) |
| Mar 2018 | - | -25.03%(+57.2%) |
| Dec 2017 | -23.32%(-83.5%) | -15.92% |
| Dec 2016 | -141.42% | - |
FAQ
- What is Y-mAbs Therapeutics annual return on equity?
- What is the all time high annual ROE for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual ROE year-on-year change?
- What is Y-mAbs Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly ROE year-on-year change?
What is Y-mAbs Therapeutics annual return on equity?
The current annual ROE of YMAB is -20.39%
What is the all time high annual ROE for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual return on equity is -20.39%
What is Y-mAbs Therapeutics annual ROE year-on-year change?
Over the past year, YMAB annual return on equity has changed by +45.67% (+69.13%)
What is Y-mAbs Therapeutics quarterly return on equity?
The current quarterly ROE of YMAB is -24.45%
What is the all time high quarterly ROE for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly return on equity is -15.92%
What is Y-mAbs Therapeutics quarterly ROE year-on-year change?
Over the past year, YMAB quarterly return on equity has changed by -6.25% (-34.34%)